Class II โ€” Potential Health Hazard

Potential health hazard โ€” use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations: Firm did not adequately investigate customer...

Date: April 22, 2015
Company: Wockhardt Usa Inc.
Status: Terminated
Source: FDA (Drug)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Wockhardt Usa Inc. directly.

Affected Products

Famotodine Tablets, USP, 40 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-937-01), B) 100 Count Bottles (NDC: 64679-937-02), and C) 1000 Count Bottles (NDC: 64679-937-03), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.

Quantity: A) 70,428 Bottles, B) 128,420 Bottles, and C) 8,101 Bottles.

Why Was This Recalled?

CGMP Deviations: Firm did not adequately investigate customer complaints.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Wockhardt Usa Inc.

Wockhardt Usa Inc. has 45 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report